BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3156148)

  • 1. A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function.
    Rajagopalan S; Gonias SL; Pizzo SV
    J Clin Invest; 1985 Feb; 75(2):413-9. PubMed ID: 3156148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
    Gonias SL; Einarsson M; Pizzo SV
    J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolism of streptokinase and polyethylene glycol-streptokinase: evidence for transport of intact forms through the biliary system in the mouse.
    Brucato FH; Pizzo SV
    Blood; 1990 Jul; 76(1):73-9. PubMed ID: 2142009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
    Wohl RC; Arzadon L; Summaria L; Robbins KC
    J Biol Chem; 1977 Feb; 252(4):1141-7. PubMed ID: 851483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.
    Anonick PK; Vetter WH; Gonias SL
    Biochem J; 1989 Dec; 264(3):745-52. PubMed ID: 2482733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
    Toki N; Takasugi S; Sumi H; Yamura T
    Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of a bacterial plasminogen activator intermediate between streptokinase and staphylokinase.
    Sazonova IY; Houng AK; Chowdhry SA; Robinson BR; Hedstrom L; Reed GL
    J Biol Chem; 2001 Apr; 276(16):12609-13. PubMed ID: 11278483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activation kinetics of mammalian plasminogens.
    Wohl RC; Sinio L; Summaria L; Robbins KC
    Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of a novel streptokinase mutant with improved stability.
    Shi GY; Chang BI; Su SW; Young KC; Wu DH; Chang LC; Tsai YS; Wu HL
    Thromb Haemost; 1998 May; 79(5):992-7. PubMed ID: 9609235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH; Summaria L; Robbins KC
    Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of acyl-plasmin-streptokinase complex with polyethylene glycol. Reduction of sensitivity to neutralizing antibody.
    Tomiya N; Watanabe K; Awaya J; Kurono M; Fujii S
    FEBS Lett; 1985 Nov; 193(1):44-8. PubMed ID: 2933274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human and bovine plasminogens by the microplasmin and streptokinase complex.
    Shi GY; Change BI; Wu DH; Ha YM; Wu HL
    Thromb Res; 1990 May; 58(3):317-29. PubMed ID: 2141198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator activities of equimolar complexes of streptokinase with variant recombinant plasminogens.
    Davidson DJ; Higgins DL; Castellino FJ
    Biochemistry; 1990 Apr; 29(14):3585-90. PubMed ID: 2141279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of activator on the esterase activity of plasmin obtained by streptokinase].
    Potron G; Droulle-Bertignon C; Ledoyen MP
    C R Seances Soc Biol Fil; 1975; 169(4):1029-33. PubMed ID: 2372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinetics of in vitro fibrinolysis by plasmin and a plasmin-streptokinase equimolar complex].
    Aĭsina RB; Zhitkova IuV; Eremeev NL; Popova GIu; Kazanskaia NF
    Ukr Biokhim Zh (1978); 1991; 63(1):20-6. PubMed ID: 1827551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
    Guinn L; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):315-20. PubMed ID: 14743974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Theoretical bases of thrombolytic therapy].
    Verstraete M
    Pathol Biol (Paris); 1975 Mar; 23(3):239-45. PubMed ID: 124849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.